Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Advertisers
    • Editorial Board
  • Other Publications
    • Anticancer Research
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • In Vivo
    • Anticancer Research
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
In Vivo
  • Other Publications
    • In Vivo
    • Anticancer Research
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
In Vivo

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Advertisers
    • Editorial Board
  • Other Publications
    • Anticancer Research
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Visit iiar on Facebook
  • Follow us on Linkedin
Research ArticleClinical Studies

Malnutrition and Survival – Bioimpedance Data in Head Neck Cancer Patients

JUDITH BÜNTZEL, OLIVER MICKE, KLAUS KISTERS, JENS BÜNTZEL and RALPH MÜCKE
In Vivo May 2019, 33 (3) 979-982; DOI: https://doi.org/10.21873/invivo.11567
JUDITH BÜNTZEL
1Department of Hematology, Medical Oncology, University Hospital Göttingen, Göttingen, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: judith.buentzel@med.uni-goettingen.de
OLIVER MICKE
2German Study Group ‘Trace Elements and Electrolytes in Oncology’ (AKTE), Bielefeld, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
KLAUS KISTERS
2German Study Group ‘Trace Elements and Electrolytes in Oncology’ (AKTE), Bielefeld, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
JENS BÜNTZEL
2German Study Group ‘Trace Elements and Electrolytes in Oncology’ (AKTE), Bielefeld, Germany
3Department of Otolaryngology, Head Neck Surgery, Südharz Hospital, Nordhausen, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
RALPH MÜCKE
2German Study Group ‘Trace Elements and Electrolytes in Oncology’ (AKTE), Bielefeld, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Abstract

Background/Aim: Bioimpedance analysis (BIA) reflects the nutritional status of patients. The aim of this study was to examine whether BIA is able to document the possible impact of malnutrition on survival. Materials and Methods: The registered data of 42 head and neck cancer patients were analyzed. Survival data of 22 women and 20 men were included. The mean age was 67.3±10.77 years. BIA was measured by the Biocorpus 4000 RX (MEDIcal Health Care GmbH Karlsruhe) and summarized in individual phase angle (PA) of each patient. Results: Patients with normal PA>5.0 had a significantly better survival (p=0.016). The median survival time was 13.84 months (range=0.69-125.19 months) in malnourished patients (PA<5.0) compared to 51.16 months (range=7.02-116.79 months) in normally nourished head and neck cancer (HNC) patients (PA>5.0). Age adjusted body mass index had a similar impact on prognosis, but was not statistically significant (p=0.068) in the investigated study groups. Conclusion: BIA is able to document the impact of malnutrition on the survival of head and neck cancer patients.

  • Malnutrition
  • bioimpedance analysis
  • head and neck cancer
  • body mass index
  • prognosis

Malnutrition is a great problem for head and neck cancer patients. The majority of them are already suffering from a bad nutritional status at the time of diagnosis (1). About 90% will develop additional symptoms such as dry mouth, loss of taste, loss of appetite, nausea and vomiting as a consequence of anti-cancer therapy. Furthermore, a third of all patients will develop late toxicities such as xerostomia and fibrotic stenosis, which disturb normal eating for the rest of their life (2).

Until today, nutrition was a central theme among cancer patients and their physicians. Screening tools such as the NRS 2002 or the MUST Score are using standardized questions or global information regarding general appearance (3, 4). Sometimes laboratory data regarding total protein or albumin are used to describe malnutrition (5).

There is need to develop tools to objectively measure malnutrition, cachexia or sarcopenia. The oldest marker of nutritional status is age-adjusted body mass index (BMI) (6, 7). However, BMI has a low sensitivity to recognize malnourished patients. Anthropometric data like skin fold measurements and dynamic hand craft are also able to describe body status, e.g. malnutrition as a complex phenomenon (8-10).

In order to better characterize body composition or muscle mass, more invasive methods such as DEXA, CT or bio-impedance-analysis-based measurements should be used (11).

This study investigated the possible advantages of bioimpedance analysis (BIA) in comparison to age-adjusted body mass index in advanced head and neck cancer patients.

Patients and Methods

Patients suffering from head and neck cancer were included into a non-interventional, anonymous, mono-institutional, retrospective register study. Treatment and follow-up performed at the department of ENT Diseases, Head Neck Surgery of the Südharz Hospital Nordhausen between 2008 and 2018.

Treatment included surgery and additional radiotherapy or primary radiochemotherapy in all patients. The follow-up visits were performed bi-monthly during the first 2 years and every 6months thereafter.

Under therapy and/ or follow-up, BIA of all patients was measured by Biocorpus 4000 RX (MEDIcal Health Care GmbH Karlsruhe). BIA yielded reactance and resistance as raw data, both were required to calculate PA. The individual PA and additional anthropometric measurements (body length, body mass) of each patient were obtained at the time of BIA by qualified staff.

Information on overall survival was extracted from follow-up files. At first, the study population was divided into two groups-PA<5° and PA>5°. Afterwards PA and overall survival were used for Kaplan–Meier calculations performed using MS excel and an add-in [Cs_Dbp_Km, University of Halle, (12)]. Secondly, the same analysis was performed for a BMI less or more than 23 kg/m2.

A phase angle (PA) >°5.0 and a BMI >23.0 kg/m2 defined normal nutritional status for patients older than 55 years.

All research was performed in accordance with the actual version of declaration of Helsinki. No further ethical approval was necessary because this observational study was anonymous and non-interventional.

Results

A total of 42 patients suffering from head-neck cancer were included in this retrospective observational study (for patient characteristics refer to Table I). Cancer entities were heterogeneous: oropharyngeal carcinoma (n=15), laryngeal cancer (n=7), oral cancer (n=5), hypopharyngeal carcinoma (n=4), neoplasm of the salivary glands (n=4), others (n=7). The histology of all samples was squamous cell carcinoma of the head and neck region. The standard of treatment was similar – surgery plus adjuvant radio(chemo)therapy.

A total of 24/42 (57.1%) patients were normally nourished (PA>5°), 11 patients had a high-risk for malnutrition (PA 4°-5°) and 7 patients were malnourished (PA<4°).

A total of 19/42 (45.2%) patients had a body mass index lower than the age adapted norm (<23.0 kg/m2).

Patients with a PA>5° showed a significantly better overall survival (p=0.016; Figure 1). Median survival in this group was 51.16 months (range=7.02-116.79 months), while median survival of malnourished patients was 13.84 months (range=0.69-125.19 months). BMI was similar in both patient groups; no significant difference was found (Table I).

Patients with BMI>23.0 kg/m2 had a better overall survival (p=0.068). As shown in Figure 2, patients with a normal BMI live for a median of 55.66 months (range=7.02-125.19 months) compared to 14.89 months (range=0.89-82.98 months) for patients with BMI <23 kg/m2. Table II summarizes the biometric data of the BMI subgroup analysis.

Discussion

In 2017, the European Society of Parenteral and Enteral Nutrition (ESPEN) published the last version of a consensus paper on the definition of cachexia and malnutrition. Unexpected weight loss, and decreased BMI are listed as main criteria. Reduced fat free mass was added as a new parameter. No consensus was reached regarding which method is the best for evaluating malnutrition (13).

Bioelectrical impedance analysis is an established method in diagnosing sarcopenia or malnutrition of cancer patients (14-16). The PA is a summarized central parameter to classify BIA's measurements (17) used in previous studies to assess malnutrition in head and neck cancer (HNC) patients (18).

View this table:
  • View inline
  • View popup
  • Download powerpoint
Table I.

Biometric data, sub-analysis according to BIA phase angle (PA)

View this table:
  • View inline
  • View popup
  • Download powerpoint
Table II.

Biometric data, sub-analysis according to body mass index (BMI).

We observed that a PA<5° was a sufficient threshold for identifying HNC patients with a shorter median survival. These results correspond to a study of patients undergoing cardiac surgery, where a PA<4.5° was indicative for a higher frailty and mortality (19). Another study on palliative care patients suffering mainly from gastric cancer set the PA threshold at <4°. Interestingly, in this study, patients with a PA>4° showed a nearly twofold increase in median survival time (20). Furthermore, a study with a patient cohort similar to ours proposed that a cutoff value of 5.95° provides the best prediction of 5-year survival in patients with HNC (21). In accordance to these previously published studies, our results indicate that BIA is a sensitive marker for identifying patients at risk.

BMI is influenced by age; generally a slightly higher BMI is recommended in the elderly (6, 7). Therefore, a BMI threshold of 23 kg/m2 was chosen. There was a trend towards longer survival in patients with a BMI>23 kg/m2. Noticeably, even age-adjusted BMI did not detect seven patients with a PA<5°. While four of these patients were only at increased risk, three were malnourished (PA<4°). On the other hand, age adjusted BMI detected eight patients with a PA>5°. Considering that patients with a BMI<23 kg/m2 showed a trend towards a shorter overall survival, this subgroup of patients also seems to be at risk. This argues for combining both parameters.

Figure 1.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 1.

Overall survival (Kaplan–Meier) according to BIA phase angle (p=0.016).

This small mono-institutional study indicates the need to establish diagnosis of nutritional status in a different manner. Anamnestic tools would be Nutritional Risk Score (NRS) 2002 or MUST (3, 4). The measurement of body mass and body length has to be a minimum standard in each oncology department. In addition, bioimpedance analysis and calculation of age-adjusted body mass index should also be performed before interpretation.

Focusing on head and neck cancer patients, malnutrition has to be treated as early as possible. Early integration could improve the outcome of standard treatment. Similar concepts are known from fast-track surgery for other cancer patients. A former study has indicated a better outcome from radiotherapy if patients have had early energy substitution (22).

Figure 2.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 2.

Overall survival (Kaplan–Meier) according to age-adjusted BMI (p=0.068).

Footnotes

  • Authors' Contributions

    Judith Büntzel: data analysis, writing, editing; Oliver Micke: conceptualization; Klaus Kisters: supervising; Jens Büntzel: data sampling, data analysis; Ralph Mücke: supervising.

  • This article is freely accessible online.

  • Conflicts of Interest

    There are no conflicts of interest to declare regarding this study.

  • Received February 14, 2019.
  • Revision received March 10, 2019.
  • Accepted March 12, 2019.
  • Copyright© 2019, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved

References

  1. ↵
    1. Müller-Richter U,
    2. Betz C,
    3. Hartmann S,
    4. Brands RC
    : Nutrition management for head and neck cancer patients improves clinical outcome and survival. Nutr Res NY N 48: 1-8, 2017. PMID: 29246276. DOI: 10.1016/j.nutres.2017.08.007
    OpenUrl
  2. ↵
    1. Büntzel J,
    2. Glatzel M,
    3. Mücke R,
    4. Micke O,
    5. Bruns F
    : Influence of amifostine on late radiation-toxicity in head and neck cancer--a follow-up study. Anticancer Res 27: 1953-1956, 2007. PMID: 17649803.
    OpenUrlAbstract/FREE Full Text
  3. ↵
    1. Elia M
    : The “MUST” report. Nutritional screening for adults: a multidisciplinary responsibility. Development and use of the “Malnutrition Universal Screening Tool” (MUST) for adults., 2003. Available from: https://eprints.soton.ac.uk/362499/[last accessed February 10, 2019].
  4. ↵
    1. Kondrup J,
    2. Rasmussen HH,
    3. Hamberg O,
    4. Stanga Z,
    5. Ad Hoc ESPEN Working Group
    : Nutritional risk screening (NRS 2002): A new method based on an analysis of controlled clinical trials. Clin Nutr Edinb Scotl 22: 321-336, 2003. PMID: 12765673.
    OpenUrl
  5. ↵
    1. Arends J,
    2. Bachmann P,
    3. Baracos V,
    4. Barthelemy N,
    5. Bertz H,
    6. Bozzetti F,
    7. Fearon K,
    8. Hütterer E,
    9. Isenring E,
    10. Kaasa S,
    11. Krznaric Z,
    12. Laird B,
    13. Larsson M,
    14. Laviano A,
    15. Mühlebach S,
    16. Muscaritoli M,
    17. Oldervoll L,
    18. Ravasco P,
    19. Solheim T,
    20. Strasser F,
    21. de van der Schueren M,
    22. Preiser J-C
    : ESPEN guidelines on nutrition in cancer patients. Clin Nutr Edinb Scotl 36: 11-48, 2017. PMID: 27637832. DOI: 10.1016/j.clnu.2016.07.015
    OpenUrl
  6. ↵
    1. Yi SW,
    2. Ohrr H,
    3. Shin SA,
    4. Yi JJ
    : Sex-age-specific association of body mass index with all-cause mortality among 12.8 million Korean adults: A prospective cohort study. Int J Epidemiol 44: 1696-1705, 2015. PMID: 26208807. DOI: 10.1093/ije/dyv138
    OpenUrlCrossRefPubMed
  7. ↵
    1. Adolph M
    : Ernährungsmedizin: Nach dem neuen Curriculum Ernährungsmedizin der Bundesärztekammer; 276 Tabellen. Georg Thieme Verlag, 2010.
  8. ↵
    1. Beaudart C,
    2. McCloskey E,
    3. Bruyère O,
    4. Cesari M,
    5. Rolland Y,
    6. Rizzoli R,
    7. Araujo de Carvalho I,
    8. Amuthavalli Thiyagarajan J,
    9. Bautmans I,
    10. Bertière M-C,
    11. Brandi ML,
    12. Al-Daghri NM,
    13. Burlet N,
    14. Cavalier E,
    15. Cerreta F,
    16. Cherubini A,
    17. Fielding R,
    18. Gielen E,
    19. Landi F,
    20. Petermans J,
    21. Reginster JY,
    22. Visser M,
    23. Kanis J,
    24. Cooper C
    : Sarcopenia in daily practice: Assessment and management. BMC Geriatr 16: 170, 2016. PMID: 27716195. DOI: 10.1186/s12877-016-0349-4
    OpenUrl
    1. Ng WL,
    2. Collins PF,
    3. Hickling DF,
    4. Bell JJ
    : Evaluating the concurrent validity of body mass index (BMI) in the identification of malnutrition in older hospital inpatients. Clin Nutr Edinb Scotl, 2018. PMID: 30501917. DOI: 10.1016/j.clnu.2018.10.025
  9. ↵
    1. Büntzel J,
    2. Putziger J,
    3. Büntzel H,
    4. Gäbert J,
    5. Oehler W
    : Ernährungsmedizinische Diagnostik für HNO-Tumorpatienten: eine kritische Analyse. M0109; 81. Jahresverdammlung der Deutschen Gesellschaft für Hals-Nasen-Ohren-Heilkunde, Kopf- und Hals-Chirurgie; Wiesbaden, DOI: 10.3205/10hno142
  10. ↵
    1. Ebner N,
    2. Haehling S von
    : Kachexie und sarkopenie bei chronischer herzinsuffizienz. Internist 59: 439-444, 2018. PMID: 29637239. DOI: 10.1007/s00108-018-0408-3
    OpenUrl
  11. ↵
    1. Universitätsklinikum Halle(Saale)
    : Excel®-Tools. Available from: https://www.medizin.uni-halle.de/index.php?id=1358 [last accessed February 10, 2019].
  12. ↵
    1. Arends J,
    2. Baracos V,
    3. Bertz H,
    4. Bozzetti F,
    5. Calder PC,
    6. Deutz NEP,
    7. Erickson N,
    8. Laviano A,
    9. Lisanti MP,
    10. Lobo DN,
    11. McMillan DC,
    12. Muscaritoli M,
    13. Ockenga J,
    14. Pirlich M,
    15. Strasser F,
    16. de van der Schueren M,
    17. Van Gossum A,
    18. Vaupel P,
    19. Weimann A
    : ESPEN expert group recommendations for action against cancer-related malnutrition. Clin Nutr Edinb Scotl 36: 1187-1196, 2017. PMID: 28689670. DOI: 10.1016/j.clnu.2017.06.017
    OpenUrl
  13. ↵
    1. Chen L-K,
    2. Liu L-K,
    3. Woo J,
    4. Assantachai P,
    5. Auyeung T-W,
    6. Bahyah KS,
    7. Chou M-Y,
    8. Chen L-Y,
    9. Hsu P-S,
    10. Krairit O,
    11. Lee JSW,
    12. Lee W-J,
    13. Lee Y,
    14. Liang C-K,
    15. Limpawattana P,
    16. Lin C-S,
    17. Peng L-N,
    18. Satake S,
    19. Suzuki T,
    20. Won CW,
    21. Wu C-H,
    22. Wu S-N,
    23. Zhang T,
    24. Zeng P,
    25. Akishita M,
    26. Arai H
    : Sarcopenia in Asia: consensus report of the Asian Working Group for Sarcopenia. J Am Med Dir Assoc 15: 95-101, 2014. PMID: 24461239. DOI: 10.1016/j.jamda.2013.11.025
    OpenUrlCrossRefPubMed
    1. Cruz-Jentoft AJ,
    2. Baeyens JP,
    3. Bauer JM,
    4. Boirie Y,
    5. Cederholm T,
    6. Landi F,
    7. Martin FC,
    8. Michel J-P,
    9. Rolland Y,
    10. Schneider SM,
    11. Topinková E,
    12. Vandewoude M,
    13. Zamboni M,
    14. European Working Group on Sarcopenia in Older People
    : Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People. Age Ageing 39: 412-423, 2010. PMID: 20392703. DOI: 10.1093/ageing/afq034
    OpenUrlCrossRefPubMed
  14. ↵
    1. Fearon K,
    2. Strasser F,
    3. Anker SD,
    4. Bosaeus I,
    5. Bruera E,
    6. Fainsinger RL,
    7. Jatoi A,
    8. Loprinzi C,
    9. MacDonald N,
    10. Mantovani G,
    11. Davis M,
    12. Muscaritoli M,
    13. Ottery F,
    14. Radbruch L,
    15. Ravasco P,
    16. Walsh D,
    17. Wilcock A,
    18. Kaasa S,
    19. Baracos VE
    : Definition and classification of cancer cachexia: an international consensus. Lancet Oncol 12: 489-495, 2011. PMID: 21296615. DOI: 10.1016/S1470-2045(10)70218-7
    OpenUrlCrossRefPubMed
  15. ↵
    1. Kumar S,
    2. Dutt A,
    3. Hemraj S,
    4. Bhat S,
    5. Manipadybhima B
    : Phase Angle Measurement in Healthy Human Subjects through Bio-Impedance Analysis. Iran J Basic Med Sci 15: 1180-1184, 2012. PMID: 23653848.
    OpenUrl
  16. ↵
    1. Büntzel J,
    2. Büntzel H,
    3. Micke O,
    4. Mücke R,
    5. Kisters K,
    6. Hübner J,
    7. Schäfer U,
    8. Boehme R,
    9. Oehler W
    : Nutritional support for head and neck cancer patients before irradiation – a pilot project for malnutrition risk group. Trace Elem Electroly 31: 1-5, 2014. DOI: 105414TEX01310, 5414.
    OpenUrl
  17. ↵
    1. Mullie L,
    2. Obrand A,
    3. Bendayan M,
    4. Trnkus A,
    5. Ouimet M-C,
    6. Moss E,
    7. Chen-Tournoux A,
    8. Rudski LG,
    9. Afilalo J
    : Phase angle as a biomarker for frailty and postoperative mortality: The BICS Study. J Am Heart Assoc 7: e008721, 2018. PMID: 30371163. DOI: 10.1161/JAHA.118.008721
    OpenUrl
  18. ↵
    1. Pérez Camargo DA,
    2. Allende Pérez SR,
    3. Verastegui Avilés E,
    4. Rivera Franco MM,
    5. Meneses García A,
    6. Herrera Gómez Á,
    7. Urbalejo Ceniceros VI
    : Assessment and impact of phase angle and sarcopenia in palliative cancer patients. Nutr Cancer 69: 1227-1233, 2017. PMID: 29083245. DOI: 10.1080/01635581.2017.1367939
    OpenUrl
  19. ↵
    1. Axelsson L,
    2. Silander E,
    3. Bosaeus I,
    4. Hammerlid E
    : Bioelectrical phase angle at diagnosis as a prognostic factor for survival in advanced head and neck cancer. Eur Arch Otorhinolaryngol 275: 2379-2386, 2018. PMID: 30046911. DOI: 10.1007/s00405-018-5069-2
    OpenUrl
  20. ↵
    1. Büntzel J,
    2. Krauß T,
    3. Büntzel H,
    4. Küttner K,
    5. Fröhlich D,
    6. Oehler W,
    7. Glatzel M,
    8. Wackes M,
    9. Putziger J,
    10. Micke O,
    11. Kisters K,
    12. Mücke R
    : Nutritional parameters for patients with head and neck cancer. Anticancer Res 32: 2119-2123, 2012. PMID: 22593498.
    OpenUrlAbstract/FREE Full Text
PreviousNext
Back to top

In this issue

In Vivo
Vol. 33, Issue 3
May-June 2019
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on In Vivo.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Malnutrition and Survival – Bioimpedance Data in Head Neck Cancer Patients
(Your Name) has sent you a message from In Vivo
(Your Name) thought you would like to see the In Vivo web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
11 + 5 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Malnutrition and Survival – Bioimpedance Data in Head Neck Cancer Patients
JUDITH BÜNTZEL, OLIVER MICKE, KLAUS KISTERS, JENS BÜNTZEL, RALPH MÜCKE
In Vivo May 2019, 33 (3) 979-982; DOI: 10.21873/invivo.11567

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
Malnutrition and Survival – Bioimpedance Data in Head Neck Cancer Patients
JUDITH BÜNTZEL, OLIVER MICKE, KLAUS KISTERS, JENS BÜNTZEL, RALPH MÜCKE
In Vivo May 2019, 33 (3) 979-982; DOI: 10.21873/invivo.11567
Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Patients and Methods
    • Results
    • Discussion
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • Body composition and dietary intake in patients with head and neck cancer during radiotherapy: a longitudinal study
  • Safety of Prophylactic Gastrostomy Tube Placement and Gastrostomy Tube Usage in Patients Treated by Radio(chemo)therapy for Head and Neck Cancer
  • Google Scholar

More in this TOC Section

  • Response to Letter to the Editor from Finsterer: “Encephalitis Associated With SARS-CoV-2 Infection in a Child With Chiari Malformation Type I”
  • Solitary Fibrous Tumor in the Retroperitoneal Space Arising from the Diaphragm
  • The Relationship Between Oxidative Stress, Selenium, and Cumulative Risk in Metabolic Syndrome
Show more Clinical Studies

Similar Articles

Keywords

  • malnutrition
  • bioimpedance analysis
  • Head and neck cancer
  • Body mass index
  • prognosis
In Vivo

© 2023 In Vivo

Powered by HighWire